Insilico Medicine Hong Kong Limited

This early-phase study tests a new drug called ISM5939 in people with advanced or metastatic solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. About 159 participants will receive the drug alo…

This early-phase study tests the safety and tolerability of a new oral drug called ISM8969 in healthy adults, elderly adults, and obese adults at risk for heart disease. About 100 participants will receive either the drug or a placebo to check for side effects and how the drug mo…